🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized pilot clinical trial studied whether the Oncotype DX gene e...
Status
Completed
Location
Washington Cancer Institute
Start Date
2011-04
Trial ID
NCT01293032
The purpose of this study is to determine whether IMC-A12 offers increased ...
Status
Completed
Location
ImClone Investigational Site
Start Date
2008-08
Trial ID
NCT00728949
Treatments Being Tested
The subjects in this trial have been diagnosed as having a pre-cancerous di...
Status
Terminated
Location
Norris Comprehensive Cancer Center
Start Date
2006-08
Trial ID
NCT00183963
Treatments Being Tested
the study aims to detect the benefit of maintenance tamoxifen after achievi...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-04
Trial ID
NCT06355401
Treatments Being Tested
Primary objective: To assess the efficacy of adding raloxifene as an adjunc...
Status
Completed
Location
Fundació Sant Joan de Déu
Start Date
2004-06
Trial ID
NCT01041092
Treatments Being Tested
Phase III clinical trial to study quality of life in prostate cancer patien...
Status
Completed
Location
Multiple Locations
Start Date
2005-06
Trial ID
NCT02382094
Treatments Being Tested
The purpose of this study is to determine if it is feasible for women to ta...
Status
Active Not Recruiting
Location
Norwalk Hospital
Start Date
2018-09-14
Trial ID
NCT03707340
Treatments Being Tested
This is a Phase 2 study to demonstrate the safety and efficacy of SFX-01 wh...
Status
Completed
Location
Grand Hopital de Charleroi, Service D'Oncologie-Hematologie
Start Date
2016-10
Trial ID
NCT02970682
Treatments Being Tested
The purpose of this research project is to study the effect of a research (...
Status
Completed
Location
Loyola Univeristy Medical Center, Cardinal Bernardin Cancer Center
Start Date
2008-02-14
Trial ID
NCT00756717
Treatments Being Tested
RATIONALE: Monoclonal antibodies such as trastuzumab can locate tumor cells...
Status
Completed
Location
NYU School of Medicine's Kaplan Comprehensive Cancer Center
Start Date
1999-03
Trial ID
NCT00009997